Healthcare Markets
Healthcare Markets
Encouraging Competition and Efficiency
Our researchers explore strategies for a patient-centered marketplace that lowers medical costs while expanding access to quality care.
Featured White Paper
U.S. Consumers Overpay for Generic Drugs
Tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, are costing patients, employers and the government billions for what should be inexpensive medicines.
Experts: Erin Trish, Karen Van Nuys
Top Healthcare Markets Stories View All
Perspective
What I Got Wrong About the Affordable Care Act — and How to Fix It
Featured Experts: Dana Goldman
In The News View All
Los Angeles Times
Melnick explains how hospital consolidation drives up costs, putting pressure on employer health plans
Featured Experts: Glenn Melnick
Politico
Joyce interviewed about California’s effort to sell cheaper, state-branded generic drugs
Featured Experts: Geoffrey Joyce
STAT News
Kanter’s research finds patient reps on FDA advisory committees often have ties to pharma-funded groups
Featured Experts: Genevieve P. Kanter
KFF Health News
Money raised by California’s proposed wealth tax may be used for purposes besides healthcare, Melnick says
Featured Experts: Glenn Melnick
Healthcare Brew
Padula discusses the economics and patient care risks of cancer drug shortages
Featured Experts: William Padula
Related Subtopics
Competition is essential for a properly functioning marketplace, but industry consolidation, insurance complexity and other factors are impeding healthcare consumers from the benefits of good commerce. Our experts explore ways to remove those obstacles to efficiency, while also promoting optimal care.
Team View All Healthcare Markets Experts
